Use of Flutter VRP1 in the management of patients with steroid-dependent asthma

Swift, G. L., Rainer, Timothy ORCID: https://orcid.org/0000-0003-3355-3237, Saran, R., Campbell, I. A. and Prescott, R. J. 1994. Use of Flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration 61 (3) , pp. 126-129. 10.1159/000196323

Full text not available from this repository.

Abstract

We have assessed a new positive expiratory pressure device, the Flutter VRP1, in 20 patients with moderately severe asthma. Patients were studied for an initial 1-week ‘run-in’ period, followed by 2 weeks of the flutter device in one of which the ball-bearing was removed from the bowl. Peak expiratory flow rates, salbutamol inhaler requirements and visual analogue scores were recorded daily. Ease of sputum expectoration showed a significant improvement after 6 days of the flutter device, but there were no differences in objective measurements of lung function nor in salbutamol use. The device may be a useful adjunct to asthma therapy.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	Asthma; Positive end-expiratory pressure
Publisher:	Karger
ISSN:	0025-7931
Date of Acceptance:	27 January 1994
Last Modified:	01 Nov 2022 10:49
URI:	https://orca.cardiff.ac.uk/id/eprint/92964

Citation Data

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item